Sirius Therapeutics Co., Ltd.

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study of SRSD384 in Overweight or Obese Participants	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Not yet recruiting	Phase 1 / Phase 2	2026-06-05	NCT07557355
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease	Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, peripheral arterial disease, peripheral vascular disease, vascular disorder	Recruiting	Phase 2	2026-04-29	NCT07318155
A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA	Embolism and Thrombosis, Thromboembolism, cardiovascular disorder, vascular disorder, venous thromboembolism	Recruiting	Phase 2	2026-01-15	NCT07140523
A Study of SRSD216 in Patients With Elevated Lipoprotein (a)	Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hyperlipoproteinemia, metabolic disease	Recruiting	Phase 1 / Phase 2	2026-01-06	NCT07172646

Clinical trials